Why IMU is a multi multi bagger, page-1736

"The way I see it is that Mason has done a lot of work to try and understand some of the finer details re IMU."

I don't see it that way.

If we just look at his/her last point as an example, why did imu go for CD19.

There has been loads of data and videos released saying how promising the CF33/CD19 combination is. To question imu taking on a product which complements our existing drug is pretty daft imho, and flies in the face of all of the experts commentary.

He/she hasn't asked a varied range of questions. He/she has asked a number of questions where he/she sees negatives or discrepancies. And he/she has posted them on this web forum.

If one really wanted to know the answer to these questions one would ask Leslie or part of the imu team (well I certainly would).

I think it's poor form.